Valued at USD 23.70 billion in 2024, the opioid market is projected to reach USD 24.14 billion in 2025 and USD 28.45 billion by 2034, growing at a CAGR of 1.8% during the forecast period 2025–2034, according to Polaris Market Research. Growing awareness of pain management options and the rising burden of injuries are the main demand drivers. Key players include Aurobindo Pharma Limited, Assertio Therapeutics, Inc., AbbVie Inc., Amneal Pharmaceuticals LLC, Boehringer Ingelheim International GmbH, Fresenius Kabi, Mallinckrodt Pharmaceuticals, Endo International plc, Johnson & Johnson Corporation, Pfizer Inc., Purdue Pharma L.P., Sun Pharmaceutical Industries Limited, Trevena Inc., and Teva Pharmaceutical Industries Ltd.

Demand Foundations in the Opioid Market

Opioids are a class of drugs commonly used for pain relief. Public awareness campaigns and training programs for healthcare providers highlight the importance of a comprehensive approach to pain management, which the report links to higher prescription rates. The American Pain Society reports that nearly 50 million adults in the US suffer from chronic pain, creating significant demand for effective relief solutions. Medical guidelines increasingly incorporate opioids into a broader pain management strategy, and providers are gaining confidence in prescribing them.

Key Growth Drivers

The first driver is the increasing prevalence of traumatic injuries. According to the American Association for Surgery of Trauma, the US records about 1.5 million traumatic brain injury cases annually, with around 230,000 individuals hospitalized. Such traumatic injuries frequently lead to persistent pain, and the CDC reports that pain management is a critical component of care for people suffering from them.

The second driver is investment in healthcare infrastructure. Government spending to expand infrastructure and reduce urban-rural disparities is expected to increase patient care services. In 2021, India's Ministry of Health and Family Welfare announced the Ayushman Bharat Health Infrastructure Mission, with an outlay of about USD 7.7 billion over six years and a component to establish Critical Care Hospitals in 602 districts. The report concludes that better access to healthcare infrastructure enables more patients to receive timely treatment for acute and chronic conditions.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/opioid-market

Release Type and Application Insights

By release type, the market is divided into immediate-release or short-acting and extended-release or long-acting opioids. Extended-release opioids are expected to grow at a higher CAGR during the forecast period, attributed to rising prevalence of extended pain and traumatic injuries requiring long-acting products, and to efforts to avoid overdose that have increased preference for long-acting opioids over short-acting versions.

By application, the pain management segment is projected to lead the market, driven by the rising prevalence of chronic and acute injuries and the resulting prescription rates. Other applications include brain disorders, cough treatment, analgesia, diarrhea treatment, and de-addiction.

Regional Analysis

North America accounted for the largest revenue share in 2024, supported by advanced healthcare infrastructure. As of 2024, the region has 7,066 hospitals, including 6,120 in the US and 946 in Canada, and the US bed count stands at 916,752. The report notes that this capacity enables timely treatment of acute and chronic pain.

Asia Pacific is expected to record the highest CAGR during the forecast period, driven by high population density, growing healthcare demand, and aging societies such as Japan and China. In India, the pharmaceutical sector has attracted about 3.32% of the USD 22.52 billion in foreign direct investment recorded from 2000 to 2024, according to Invest India.

Competitive Landscape and Regulatory Context

Leading players invest heavily in research and development, advanced manufacturing, and strategic initiatives such as mergers and acquisitions, partnerships, and collaborations. The report lists stringent government regulation as a restraint, a key consideration for any stakeholder planning market entry or portfolio expansion.

Outlook for Stakeholders

With the opioid market projected to rise from USD 24.14 billion in 2025 to USD 28.45 billion by 2034, growth is projected at a modest 1.8% CAGR. Manufacturers and investors should weigh regional infrastructure expansion, long-acting product demand, and regulatory conditions when planning strategy.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market